IOMED INC·4

Aug 13, 2:42 PM ET

IOMED INC 4

4 · IOMED INC · Filed Aug 13, 2007

Insider Transaction Report

Form 4
Period: 2007-08-09
LOLLINI ROBERT J
DirectorPresident & CEO
Transactions
  • Disposition to Issuer

    Common Stock

    2007-08-09$2.75/sh9,756$26,8290 total
  • Disposition to Issuer

    stock options

    2007-08-09$2.25/sh100,000$225,0000 total
    Exercise: $2.25From: 2007-08-09Exp: 2007-08-09common stock (100,000 underlying)
  • Disposition to Issuer

    stock options

    2007-08-09$3.24/sh28,000$90,7200 total
    Exercise: $3.24From: 2007-08-09Exp: 2007-08-09common stock (28,000 underlying)
  • Disposition to Issuer

    stock options

    2007-08-09$0.90/sh53,000$47,7000 total
    Exercise: $0.90From: 2007-08-09Exp: 2007-08-09common stock (53,000 underlying)
Footnotes (3)
  • [F1]Disposed of pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. in exchange for a cash payment of $2.75 per share on the effective date of the merger.
  • [F2]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. A cash paymetn representing the difference between the exercise price of the option and the market value of the underlying Iomed common stock on the effective date of the merger ($2.75 per share) was made.
  • [F3]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. There was no cash payment made because the option price was below the market value of the underlying Iomed common stock on the effective date of the merger.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT